Modulating the Hypoxia-Inducible Factor Signaling Pathway: Applications From Cardiovascular Disease to Cancer

E-ISSN： 1873-4286|10|8|821-833

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.8, 2004-03, pp. : 821-833

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 782-796

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Therapeutic Agents Targeting Hypoxia-Inducible Factor-1

Current Medicinal Chemistry, Vol. 18, Iss. 21, 2011-07 ,pp. : 3168-3189

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor Signaling by Plant Flavonoids

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 6, 2015-05 ,pp. : 479-489

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting hypoxia-inducible factor-1 for therapy and prevention

By Zhong Hua

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 951-966

Informa Healthcare

Access to resources Recommend Favorite

Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel–Lindau-dependent pathway

By Li Ching-Hao Liao Po-Lin Yang Ya-Ting Huang Shih-Hsuan Lin Cheng-Hui Cheng Yu-Wen Kang Jaw-Jou

Archives of Toxicology, Vol. 88, Iss. 3, 2014-03 ,pp. : 659-671

Springer Publishing Company

Access to resources Recommend Favorite